Foundational drugs for HFrEF: the growing evidence for a rapid sequencing strategy
View Full Paper
Ask AI
Bookmark
Share
Key result
Rapid sequencing establishes HFrEF patients on foundational therapies within 4 weeks versus traditional prolonged approaches.
Why the study?
Traditional initiation of foundational HFrEF therapies could take six months or more, leaving patients without life-saving drugs while an alternative rapid-sequencing strategy aims to initiate all four treatments within four weeks.
Does a rapid sequencing strategy for initiating foundational therapies improve outcomes in patients with HFrEF compared to conventional sequencing?
Comparison
Rapid three-step sequencing strategy vs traditional historical initiation and uptitration strategy
Design
Review article
Authors
Discussion
Loading...
Member takes
Implication
Should not yet change HFrEF practice; leaves open whether rapid sequencing improves outcomes versus conventional titration.
Structured PICO
Does a rapid sequencing strategy for initiating foundational therapies improve outcomes in patients with HFrEF compared to conventional sequencing?
P
Population
Patients with heart failure with reduced ejection fraction (HFrEF)
I
Intervention
Rapid three-step sequencing strategy for initiating four foundational therapies (beta blocker, SGLT2 inhibitor, ARB/neprilysin inhibitor, MRA) within four weeks
C
Comparator
Conventional guideline-advocated strategy (initiating one treatment at a time in historical order and up-titrating to target dose before adding the next, taking 6 months or more)
A novel rapid-sequencing strategy proposes initiating all four foundational HFrEF therapies within four weeks to rapidly provide independent and additive mortality and morbidity benefits, challenging traditional stepwise guidelines.
Cite This Study
Docherty et al. (2022) conducted a review in Heart failure with reduced ejection fraction (HFrEF). Rapid three-step sequencing strategy vs. Traditional historical order uptitration strategy was evaluated. A rapid three-step sequencing strategy aims to establish HFrEF patients on low doses of four foundational treatments within 4 weeks, compared to the traditional approach taking 6 months or more.
View Full Paper
Ask AI
Bookmark
Share